object
determin
clinic
present
find
outcom
older
adult
sever
acut
respiratori
syndrom
sar
compar
control
group
younger
patient
design
retrospect
cohort
studi
set
communitybas
acut
hospit
hong
kong
particip
adult
inpati
clinic
diagnosi
sar
measur
clinic
present
investig
treatment
mortal
result
young
older
patient
mean
age
ae
standard
deviat
ae
ae
respect
fever
chill
diarrhea
common
younger
patient
wherea
decreas
appetit
gener
condit
occur
older
patient
preval
posit
reversetranscriptas
polymeras
chain
reaction
sarsassoci
coronaviru
sarscov
nasopharyng
secret
stool
sampl
similar
two
group
preval
posit
serolog
test
sarscov
significantli
lower
older
patient
vs
larg
due
incomplet
test
elderli
patient
older
patient
like
develop
secondari
nosocomi
infect
admit
intens
care
unit
requir
mechan
ventil
cumul
mortal
rate
respect
young
patient
sar
respect
older
patient
conclus
older
patient
sar
often
present
nonspecif
symptom
prognosi
poor
reversetranscriptas
polymeras
chain
reaction
use
diagnos
sar
older
patient
role
serolog
test
individu
elderli
limit
ever
acut
respiratori
syndrom
sar
new
infecti
diseas
substanti
morbid
mortal
septemb
case
report
countri
region
caus
agent
novel
coronaviru
call
sarsassoci
coronaviru
sarscov
put
mode
transmiss
close
persontoperson
contact
via
droplet
fomit
sar
affect
infant
octogenarian
initi
data
suggest
case
fatal
rate
patient
age
older
rang
subsequ
studi
also
confirm
advanc
age
one
strongest
predictor
poor
outcom
although
atyp
present
sar
describ
isol
report
systemat
analys
clinic
featur
outcom
elderli
patient
sar
lack
aim
compar
clinic
cours
sar
patient
age
younger
patient
older
admit
singl
institut
clinic
diagnosi
sar
kwong
wah
hospit
major
acut
hospit
hong
kong
serv
popul
sar
outbreak
late
februari
one
design
center
receiv
referr
emerg
depart
depart
health
retrospect
studi
undertaken
depart
medicin
geriatr
hospit
evalu
clinic
cours
young
elderli
sar
patient
enrol
period
began
februari
first
index
case
hong
kong
admit
hospit
end
may
adult
inpati
met
criteria
modifi
world
health
organ
definit
sar
includ
tabl
laboratori
evid
cov
infect
prerequisit
inclus
includ
nasopharyng
swab
aspir
urin
stool
sampl
reversetranscriptas
polymeras
chain
reaction
rtpcr
sarscov
serolog
test
sarscov
immunoglobulin
g
antibodi
posit
serolog
test
defin
singl
titer
seroconvers
fourfold
increas
antibodi
titer
pair
serum
sampl
period
day
test
wide
avail
april
patient
admit
earli
die
rapidli
outbreak
undergo
investig
other
routin
test
rtpcr
cov
antibodi
microbiolog
test
also
perform
exclud
establish
caus
communityacquir
pneumonia
cap
includ
bacteri
cultur
sputum
blood
urin
serolog
test
mycoplasma
chlamydia
legionella
influenza
parainfluenza
respiratori
syncyti
viru
adenoviru
nasopharyng
swab
aspir
rapid
antigen
test
influenza
sputum
acidfast
bacillu
smear
cultur
mycobacteria
train
physician
undertook
chart
review
respiratori
physician
valid
diagnosi
demograph
data
clinic
featur
concomit
ill
contact
histori
document
contact
histori
defin
exposur
case
within
day
present
symptom
contact
histori
classifi
hospit
contact
famili
contact
commun
contact
hospit
contact
defin
histori
visit
hospit
hospit
work
hospit
within
day
present
symptom
dedic
sar
team
manag
patient
treat
accord
consensu
protocol
suggest
local
expert
panel
initi
treatment
typic
includ
combin
thirdor
fourthgener
cephalosporin
ceftriaxon
cefepim
oral
macrolid
clarithromycin
azithromycin
patient
definit
contact
histori
empir
treatment
intraven
ribavirin
mgkg
everi
hour
hydrocortison
mgkg
everi
hour
start
clinic
condit
improv
within
day
highresolut
computer
tomographi
scan
thorax
perform
suspect
case
normal
equivoc
chest
xray
find
puls
methylprednisolon
mgd
day
given
patient
rapid
clinic
radiolog
deterior
usual
ribavirin
corticosteroid
taper
period
week
oral
treatment
began
clinic
condit
stabil
admiss
intens
care
unit
icu
gener
restrict
patient
requir
mechan
ventil
patient
fair
good
premorbid
function
state
hematolog
biochem
microbiolog
test
result
record
total
ribavirin
corticosteroid
dosag
administ
also
calcul
follow
outcom
measur
requir
mechan
ventil
admiss
icu
document
nosocomi
infect
mortal
rate
patient
divid
two
group
accord
age
young
age
group
defin
younger
older
age
group
older
clinic
present
treatment
outcom
two
group
compar
descript
statist
use
summar
demograph
data
chisquar
test
mannwhitney
u
test
use
compar
categor
continu
variabl
two
group
cumul
mortal
rate
two
group
describ
accord
kaplanmei
method
unless
otherwis
state
data
express
mean
ae
standard
deviat
consid
signific
test
data
analysi
perform
use
spss
window
version
spss
corp
chicago
il
eightyon
patient
whose
clinic
featur
compat
sar
identifi
two
patient
final
diagnosi
human
immunodefici
viru
infect
one
patient
pulmonari
tuberculosi
exclud
one
patient
also
exclud
lack
fever
despit
radiolog
evid
infiltr
posit
rtpcr
sarscov
throat
swab
seventyseven
patient
fulfil
diagnost
criteria
sar
thu
avail
analysi
women
mean
age
ae
standard
deviat
ae
patient
young
older
age
group
respect
correspond
age
ae
ae
respect
clinic
featur
two
group
patient
shown
tabl
presenc
fever
admiss
chill
common
younger
age
group
wherea
decreas
appetit
gener
condit
occur
older
age
group
patient
without
fever
admiss
develop
fever
later
fiftynin
patient
abl
recal
contact
histori
exposur
classifi
hospit
contact
commun
contact
nine
famili
contact
nine
patient
histori
recent
travel
outsid
hong
kong
consid
exposur
signific
differ
variou
type
contact
histori
young
older
patient
rtpcr
sarscov
nasopharyng
secret
done
young
older
patient
wherea
rtpcr
stool
sampl
done
respect
differ
young
older
patient
posit
rtpcr
nasopharyng
aspir
vs
p
stool
sampl
vs
p
singl
pair
serum
sampl
test
sarscov
antibodi
young
older
patient
preval
posit
serolog
test
older
patient
young
patient
differ
signific
major
caus
neg
serolog
test
older
adult
incomplet
test
absenc
antibodi
test
convalesc
phase
dead
survivor
addit
three
older
patient
whose
serolog
test
remain
neg
even
day
admiss
patient
receiv
ribavirin
corticosteroid
except
two
patient
young
age
group
median
dose
ribavirin
mg
younger
patient
mg
older
patient
p
differ
median
dose
corticosteroid
hydrocortison
prednisolon
methylprednisolon
two
group
significantli
elderli
patient
develop
secondari
nosocomi
infect
pseudomona
aeruginosa
n
methicillinresist
staphylococcu
aureu
n
escherichia
coli
n
acinetobact
spp
n
vs
p
requir
mechan
ventil
vs
p
admit
icu
vs
p
three
five
older
patient
whose
cours
complic
nosocomi
infect
die
crude
fatal
rate
significantli
higher
older
age
group
v
median
time
admiss
sar
ward
death
day
older
patient
day
day
young
patient
day
caus
death
due
respiratori
failur
cumul
mortal
rate
respect
young
patient
sar
respect
older
patient
figur
elderli
patient
cap
well
recogn
present
atyp
symptom
sign
nonclass
present
includ
absenc
fever
chill
slight
cough
high
frequenc
extrapulmonari
manifest
confus
studi
confirm
present
sar
older
adult
resembl
form
cap
significantli
fewer
older
adult
present
initi
fever
chill
wherea
atyp
complaint
includ
decreas
appetit
gener
condit
occur
older
individu
symptom
sar
geriatr
patient
could
also
manifest
orthoped
complic
elderli
woman
develop
respiratori
failur
recent
oper
hip
fractur
autopsi
later
show
typic
find
sar
diarrhea
occur
younger
patient
older
patient
former
incid
compar
find
sever
larg
local
studi
report
diarrhea
sar
patient
unclear
older
adult
less
diarrhea
proport
patient
posit
rtpcr
stool
sampl
similar
two
group
fewer
older
patient
diarrhea
probabl
repres
gener
pauciti
symptom
rather
differ
site
involv
sarscov
find
bodi
temperatur
less
suggest
poor
prognost
indic
older
patient
cap
patient
sar
analyz
due
small
number
older
patient
also
trend
toward
higher
mortal
subject
without
fever
initi
lack
fever
may
impli
impair
immun
respons
infect
although
may
omin
time
elderli
patient
clinic
radiolog
laboratori
featur
sar
exclud
studi
fever
never
document
remain
well
empir
oral
ribavirin
treatment
might
repres
mild
form
sarscov
infect
import
recogn
patient
nonspecif
symptom
without
fever
infect
control
reason
epidem
outbreak
hospit
report
healthcar
worker
contract
sar
manag
unsuspect
infect
patient
gener
ward
shown
sensit
rtpcr
sarscov
vari
differ
time
sampl
sensit
rtpcr
nasopharyng
secret
vari
sampl
collect
first
day
collect
day
ill
sampl
collect
within
first
week
preval
posit
rtpcr
nasopharyng
aspir
stool
sampl
respect
two
larg
local
studi
report
posit
rate
rtpcr
nasopharyng
aspir
wherea
posit
rate
stool
sampl
one
seri
select
bia
patient
variat
sampl
time
like
reason
account
discrep
one
studi
sar
patient
rtpcr
stool
sampl
examin
contrast
patient
current
studi
current
studi
similar
proport
young
older
patient
sar
rtpcr
perform
compar
posit
rate
achiev
thu
appear
rtpcr
cov
use
diagnos
sar
older
patient
nevertheless
preval
posit
serolog
test
significantli
lower
older
patient
larg
due
incomplet
test
especi
patient
die
quickli
half
death
older
patient
occur
within
week
admiss
although
seroconvers
may
detect
day
onset
ill
addit
interv
symptom
onset
admiss
patient
might
pair
serolog
test
complet
less
day
admiss
seroconvers
might
occur
later
time
patient
howev
three
older
patient
serolog
test
remain
neg
day
mean
day
may
relat
genuin
lack
immun
respons
age
associ
qualit
declin
tcell
function
integr
helper
cell
essenti
process
antibodi
product
declin
delay
antibodi
respons
influenza
vaccin
also
demonstr
elderli
subject
antibodi
respons
sarscov
day
may
use
older
adult
sar
use
rtpcr
sarscov
sought
vigor
exclud
sar
suspect
elderli
subject
although
fewer
onequart
report
sar
patient
age
older
account
twothird
death
relat
sar
hospit
author
central
organ
committe
sar
data
august
mortal
rate
patient
age
older
sar
respect
cohort
find
similar
estim
fatal
rate
confid
interv
suggest
research
late
death
current
studi
demonstr
sar
acut
ill
high
immedi
mortal
elderli
popul
sever
larg
studi
shown
advanc
age
consist
power
independ
predictor
mortal
morbid
sar
patient
age
prognost
indic
relat
mortal
group
older
adult
cap
adjust
confound
moreov
one
recent
larg
seri
report
crude
fatal
rate
older
adult
cap
anoth
prospect
studi
evalu
group
old
patient
mean
age
cap
show
fatal
rate
caus
excess
fatal
rate
elderli
sar
patient
known
sarscov
may
particularli
virul
older
adult
remain
proven
altern
elderli
patient
may
suscept
side
effect
ribavirin
highdos
corticosteroid
use
empir
treatment
major
patient
sar
hong
kong
studi
sar
undertaken
retrospect
incid
consequ
advers
effect
relat
medic
unknown
suggest
ribavirin
might
benefici
immunomodul
despit
modest
antivir
activ
system
use
ribavirin
may
also
caus
dosedepend
hemolyt
anemia
bone
marrow
suppress
studi
signific
anemia
requir
blood
transfus
complic
cours
three
elderli
patient
two
three
patient
die
apart
ribavirin
major
sar
patient
hong
kong
also
receiv
highdos
corticosteroid
although
previou
studi
shown
corticosteroid
effect
clear
consolid
chang
patient
sar
use
corticosteroid
could
detriment
caus
immunosuppress
promot
secondari
sepsi
latter
complic
fatal
older
adult
major
elderli
patient
document
nosocomi
infect
die
major
differ
current
studi
definit
sar
latest
center
diseas
control
prevent
cdc
definit
laboratori
investig
includ
criteria
nevertheless
patient
sar
young
older
patient
also
fulfil
definit
sar
case
laboratori
confirm
patient
confirm
sarscov
antibodi
young
patient
two
posit
pcr
sarscov
young
older
patient
pcr
serolog
test
young
older
patient
older
patient
without
laboratori
confirm
serolog
test
done
dead
incomplet
serolog
test
dead
survivor
neg
serolog
test
day
admiss
survivor
nevertheless
patient
met
cdc
definit
probabl
sar
case
base
clinic
epidemiolog
radiolog
criteria
absenc
laboratori
confirm
primarili
due
unavail
test
earli
epidem
impractic
complet
test
patient
die
rapidli
sever
limit
studi
first
retrospect
studi
data
collect
might
incomplet
second
time
techniqu
collect
specimen
rtpcr
standard
exampl
nasopharyng
aspir
throat
swab
perform
collect
nasopharyng
secret
numer
staff
undertook
procedur
third
also
consider
variat
time
dosag
corticosteroid
ribavirin
prescrib
despit
presenc
treatment
protocol
rel
benefit
harm
difficult
assess
strength
studi
control
group
younger
patient
avail
comparison
data
sar
older
adult
extrem
scarc
repres
vulner
target
group
subsequ
outbreak
prognosi
poor
exist
treatment
despit
rapid
advanc
genom
sequenc
sarsassoci
cov
rapid
reliabl
laboratori
test
earli
diagnosi
sar
still
avail
recognit
nonspecif
divers
pauciti
symptom
older
adult
sar
provid
cornerston
diagnosi
anoth
epidem
reappear
prompt
isol
vigor
attempt
identifi
virus
variou
specimen
undertaken
rtpcr
sarscov
nasopharyng
secret
stool
sampl
use
older
patient
limit
role
serolog
test
older
adult
sar
